EP-1616 Population-based Phase II Trial of Stereotactic Radiotherapy for up to 5 Oligometastases: SABR-5

Autor:	Tanya Berrang, B. Mou, Scott Tyldesley, Derek Hyde, S. Lam, D. Schellenberg, Ante Mestrovic, Howard Pai, Parminder S. Basran, D. Glick, Nick Chng, Quinn Matthews, Robert Olson, Fred Hsu, C.R. Lund, Alanah Bergman, Boris Valev, Hannah Carolan, M. Liu
Rok vydání:	2019
Předmět:	Stereotactic radiotherapy Oncology business.industry Phase (waves) Medicine Radiology Nuclear Medicine and imaging Hematology Population based Nuclear medicine business SABR volatility model
Zdroj:	Radiotherapy and Oncology. 133:S871
ISSN:	0167-8140
DOI:	10.1016/s0167-8140(19)32036-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8efd42c846d1bd1729cd836d56985618 https://doi.org/10.1016/s0167-8140(19)32036-5 Zobrazit plný text záznamu Full Text from ScienceDirect